Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer (Q43549607)

24 November 2017

title

Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer (English)

1 reference

24 November 2017

main subject

phase III clinical trial

0 references

1 reference

Milla-Santos A

1

1 reference

24 November 2017

Milla L

series ordinal

2

1 reference

24 November 2017

Rallo L

series ordinal

3

1 reference

24 November 2017

Solano V

series ordinal

4

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

Breast Cancer Research and Treatment

24 November 2017

published in

1 reference

24 November 2017

volume

65

1 reference

24 November 2017

issue

2

1 reference

24 November 2017

page(s)

119-124

1 reference

Use of tamoxifen for breast cancer: twenty-eight years later

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Endometrial cancer in tamoxifen-treated breast cancer patients: findings from the National Surgical Adjuvant Breast and Bowel Project (NSABP) B-14.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Tamoxifen and toremifene in breast cancer: comparison of safety and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Apoptosis in toremifene-induced growth inhibition of human breast cancer cells in vivo and in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Toremifene. A review of its pharmacological properties and clinical efficacy in the management of advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Reporting results of cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Toxicity and response criteria of the Eastern Cooperative Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Nonparametric Estimation from Incomplete Observations

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Should clinicians be concerned about the carcinogenic potential of tamoxifen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

A Retrospective Study of Tamoxifen and Endometrial Cancer in Breast Cancer Patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Tamoxifen and secondary tumours. An update

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Genotoxicity studies with the antiestrogen toremifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Randomized comparison of tamoxifen and two separate doses of toremifene in postmenopausal patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

A phase III comparison of two toremifene doses to tamoxifen in postmenopausal women with advanced breast cancer. Eastern European Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

An analysis of variance test for normality (complete samples)

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

Adjuvant tamoxifen therapy for early stage breast cancer and second primary malignancies. Stockholm Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

inferred from DOI database lookup

7 January 2021

based on heuristic

Second cancers after adjuvant tamoxifen therapy for breast cancer

1 reference

https://api.crossref.org/works/10.1023/A:1006440802709

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1023/A:1006440802709

1 reference

Dimensions Publication ID

24 November 2017

1028126131

0 references

1 reference